Diagnosis of Chronic Pulmonary Aspergillosis: Clinical, Radiological or Laboratory?
- PMID: 37998889
- PMCID: PMC10672318
- DOI: 10.3390/jof9111084
Diagnosis of Chronic Pulmonary Aspergillosis: Clinical, Radiological or Laboratory?
Abstract
Chronic pulmonary aspergillosis (CPA) is a chronic progressive lung disease associated with a poor prognosis and a 5-year mortality rate of approximately 40-50%. The disease is characterized by slowly progressive destruction of the lung parenchyma, in the form of multiple cavities, nodules, infiltrates or fibrosis. CPA can be challenging to diagnose due to its non-specific symptoms and similarities with other respiratory conditions combined with the poor awareness of the medical community about the disease. This can result in delayed treatment even for years and worsening of the patient's condition. Serological tests certainly play a significant role in diagnosing CPA but cannot be interpreted without radiological confirmation of CPA. Although many data are published on this hot topic, there is yet no single definitive test for diagnosing CPA, and a multidisciplinary approach which involves a combination of clinical picture, radiological findings, microbiological results and exclusion of other mimicking diseases, is essential for the accurate diagnosis of CPA.
Keywords: antibody; chronic pulmonary aspergillosis; clinical symptoms; laboratory diagnosis; radiological findings.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Aspergilloma.2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31536274 Free Books & Documents.
-
Diagnostic Laboratory Features and Performance of an Aspergillus IgG Lateral Flow Assay in a Chronic Pulmonary Aspergillosis Cohort.Microbiol Spectr. 2023 Jun 15;11(3):e0026423. doi: 10.1128/spectrum.00264-23. Epub 2023 May 1. Microbiol Spectr. 2023. PMID: 37125929 Free PMC article.
-
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015. Eur Respir J. 2016. PMID: 26699723
-
Chronic pulmonary aspergillosis update: A year in review.Med Mycol. 2019 Apr 1;57(Supplement_2):S104-S109. doi: 10.1093/mmy/myy070. Med Mycol. 2019. PMID: 30816975 Review.
-
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities.Int J Tuberc Lung Dis. 2021 Jul 1;25(7):537-546. doi: 10.5588/ijtld.21.0034. Int J Tuberc Lung Dis. 2021. PMID: 34183098 Review.
Cited by
-
Risk Factors and Long-Term Prognosis for Coinfection of Nontuberculous Mycobacterial Pulmonary Disease and Chronic Pulmonary Aspergillosis: A Multicentre Observational Study in Japan.Mycoses. 2025 Jun;68(6):e70083. doi: 10.1111/myc.70083. Mycoses. 2025. PMID: 40536274 Free PMC article.
-
Deciphering the Correlation between the Emergence of Lung Carcinoma Associated with Tuberculosis-related Inflammation.Endocr Metab Immune Disord Drug Targets. 2025;25(4):291-299. doi: 10.2174/0118715303301146240522095638. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 38831573 Review.
-
A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study).J Fungi (Basel). 2025 Apr 22;11(5):329. doi: 10.3390/jof11050329. J Fungi (Basel). 2025. PMID: 40422663 Free PMC article.
-
Prevalence and clinical impact of bacterial co-infection in chronaturenic pulmonary aspergillosis.BMC Pulm Med. 2025 Apr 4;25(1):155. doi: 10.1186/s12890-025-03623-y. BMC Pulm Med. 2025. PMID: 40186176 Free PMC article.
-
Thermal ablation combined with percutaneous injection of amphotericin B for the treatment of chronic pulmonary aspergillosis: a case series.Front Med (Lausanne). 2025 Apr 16;12:1557549. doi: 10.3389/fmed.2025.1557549. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40309732 Free PMC article.
References
-
- Maruguchi N., Tanaka E., Okagaki N., Tanaka Y., Sakamoto H., Takeda A., Yamamoto R., Nakamura S., Matsumura K., Ueyama M., et al. Clinical Impact of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease and Role of Computed Tomography in the Diagnosis. Intern. Med. 2023 doi: 10.2169/internalmedicine.0836-22. online ahead of print . - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources